Abstract:Insulin fibrillation poses a significant challenge in the development and treatment of diabetes. Current efforts to unravel its mechanisms have thus far remained incomplete. To shed light on the intricate processes behind insulin fibrillation, we employed mutagenesis techniques to introduce additional positive charge residues into the C-terminal region of the insulin B chain which plays an important role in insulin dimerization. We employed our investigation with various spectroscopic methods, electron microscopy, and molecular dynamics simulations. These methods allowed us to explore the structure and fibrillation behavior of the engineered B chains following their expression in a bacterial host and successful purification. This manipulation had a pronounced impact on the oligomerization behavior of the insulin B chain. It appears that these mutations delay the formation of the dimeric state in the process of transitioning to larger oligomers, consequently, leading to an alteration in the kinetics of fibrillation. Our findings also indicated that the mutant insulin B chains (Di-R, Di-K, and Di-H) displayed resistance to the initiation of fibrillation. This resistance can be attributed to the repulsive forces generated by the introduced positive charges, which disrupt the attractive interactions favoring nucleation. Notably, the mutant B chains formed shorter and less abundant oligomers and fibrils, which can be ascribed to the alterations induced by repulsion. Our engineered mutant B chains exhibited enhanced stability against stress-induced fibrillation, hinting at their potential utility in the development of new insulin analogs. This study underscores the significance of the C-terminal region in the initial stages of insulin B chain fibrillation, providing valuable insights into the intricate mechanisms involved and their potential pharmaceutical applications.

Inhibition mechanism of human insulin fibrillation by Bodipy carbon polymer dots and photothermal defibrillation effect of Bodipy carbon polymer dots modified by ThT

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Regulation mechanism of human insulin fibrillation by L-lysine Carbon dots: low concentration accelerates but high concentration inhibits the fibrillation process

Regulation Mechanism of Human Insulin Fibrillation Byl-Lysine Carbon Dots: Low Concentration Accelerates but High Concentration Inhibits the Fibrillation Process

Active Site-Targeted Carbon Dots for the Inhibition of Human Insulin Fibrillation

Molecular Mechanisms of the Ultra-Strong Inhibition Effect of Oxidized Carbon Dots on Human Insulin Fibrillation.

Bifunctional Carbon Dots for Cell Imaging and Inhibition of Human Insulin Fibrillation in the Whole Aggregation Process.

High-Oxygen-Content Carbon Dots As a High-Efficiency Inhibitor of Human Insulin Aggregation.

Zn-doped Cu2S quantum dots as new high-efficiency inhibitors against human insulin fibrillation based on specific electrostatic interaction with oligomers

Monitoring and Modulation of Insulin Fibers by a Protein Isomerization Targeting Dye Bromophenol Blue

The Effects of A Series of Carbon Dots on Fibrillation and Cytotoxicity of Human Islet Amyloid Polypeptide

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

Effect of 33 Hz Pulsed Electric Field on Insulin Amyloidosis

Dual Functional Amphiphilic Sugar-Coated AIE-active Fluorescent Organic Nanoparticles for the Monitoring and Inhibition of Insulin Amyloid Fibrillation Based on Carbohydrate-Protein Interactions.

Charge manipulation of the human insulin B chain C-terminal to shed light on the complex mechanism of insulin fibrillation

High resolution spectroscopy reveals fibrillation inhibition pathways of insulin

Insulin Amyloid Fibrillation Studied by Terahertz Spectroscopy and Other Biophysical Methods

Photo-induced Inhibition of Insulin Amyloid Fibrillation on Online Laser Measurement.

Supramolecular Nanoparticles of Insulin and Pentapeptide for Inhibition of Fibrillation and Controlled Release

Inhibition of insulin fibrillation by carboxyphenylboronic acid-modified chitosan oligosaccharide based on electrostatic interactions and hydrophobic interactions

Efficient Encapsulation of Insulin by Giant Macrocycle as a Powerful Approach to the Inhibition of Its Fibrillation